via MS Society UK
A new study shows that intense immunosuppression followed by a hematopoietic stem cell transplant may prevent disability associated with multiple sclerosis (MS) from getting worse in 71% of people with relapsing-remitting MS for up to 10 years after the treatment.
The research is published in the January 20, 2021, online issue of Neurology®, the medical journal of the American Academy of Neurology. The study also found that in some people their disability improved over 10 years after treatment. Additionally, more than half of the people with the secondary progressive form of MS experienced no worsening of their symptoms 10 years after a transplant.
While most people with MS are first diagnosed with relapsing-remitting MS, marked by symptom flare-ups followed by periods of remission, many people with relapsing-remitting MS eventually transition to secondary progressive MS, which does not have wide swings in symptoms but instead a slow, steady worsening of the disease.
The study involved autologous hematopoietic stem cell transplants, which use healthy blood stem cells from the participant’s own body to replace diseased cells.
“So far, conventional treatments have prevented people with MS from experiencing more attacks and worsening symptoms, but not in the long term,” said study author Matilde Inglese, M.D., Ph.D., of the University of Genoa in Italy and a member of the American Academy of Neurology. “Previous research shows more than half of the people with MS who take medication for their disease still get worse over a 10-year period. Our results are exciting because they show hematopoietic stem cell transplants may prevent someone’s MS disabilities from getting worse over the longer term.”
The study looked at 210 people with MS who received stem cell transplants from 1997 to 2019. Their average age was 35. Of those people, 122 had relapsing-remitting MS and 86 had secondary progressive MS and two had primary progressive MS.
Researchers assessed participants at six months, five years and 10 years after their transplants.
Five years into the study, researchers found that 80% of the people experienced no worsening of their MS disability. At the 10-year mark, 66% still had not experienced a worsening of disability.
When looking at just the people with the most common form of MS, researchers found 86% of them experienced no worsening of their disability five years after their transplant. Ten years later, 71% still experienced no worsening of their disability.
Also, people with progressive MS benefited from stem cell transplants. Researchers found that 71% of the people with this type of MS experienced no worsening of their disability five years after their transplants. Ten years later, 57% experienced no worsening of their disability.
“Our study demonstrates that intense immunosuppression followed by hematopoietic stem cell transplants should be considered as a treatment for people with MS, especially those who don’t respond to conventional therapy,” Inglese said.
Limitations of the study include that it was retrospective, did not include a control group and the clinicians who helped measure participants’ disability were aware that they had received stem cell transplants, so that could have led to bias. Inglese said these limitations will be addressed in future research.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Stem cell transplant
- Penn State Health pausing kidney transplants
Penn State Health says they’re pausing kidney transplants at Milton S. Hershey Medical Center for two weeks. Penn State Health says the decision came after meetings with The United Network for Organ ...
- Half-matched family donors offer best outcomes for Hispanic patients undergoing bone marrow transplants: Study
For adults with acute lymphoblastic leukemia (ALL), a type of cancer that originates in the bone marrow, allogeneic stem cell transplantation (more commonly known as a bone marrow transplant) may be ...
- Half-matched family donors offer best outcomes for Hispanic patients undergoing bone marrow transplants
Compared to patients who received a bone marrow transplant from an identically matched registered donor, half-identical relative transplant recipients were more than twice as likely to avoid both ...
- Sidra Medicine to establish Qatar's first-ever Pediatric Hematopoietic Stem Cell Transplant Program
Sidra Medicine, a QF entity, announced the upcoming establishment of the first-ever pediatric hematopoietic stem cell transplant (HSCT) program in Qatar, in partnership with one ...
- Brookfield cancer patient gets ‘a second chance on life’ with stem cells from a Canadian athlete
Brookfield's Tom Mix received a bone marrow transplant at Yale New Haven with stem cells donated by Alex Pace, a professional lacrosse player from Ontario.
Go deeper with Google Headlines on:
Stem cell transplant
[google_news title=”” keyword=”stem cell transplant” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Multiple sclerosis
- What Are The Possible Complications Multiple Sclerosis? A Review By Doctors
Expert opinion from Ilya AleksandrovskiyM.D., MBA · 5 years of experience · USAMultiple sclerosis complications include the following: 1. Muscle spasms or stiffness 2. Paralysis, most commonly in the ...
- Dufferin County council proclaims May as Multiple Sclerosis Awareness, Sexual Violence Prevention Month
May in Dufferin County marks Multiple Sclerosis Awareness and Sexual Violence Prevention Month with proclamations acknowledging the impact of these issues on the community.
- Relapse Risk Higher in Nonactive MS With High-Efficacy Therapy Discontinuation
In an observational cohort study, researchers assessed whether discontinuation vs continuation of high-efficacy therapies in older patients with nonactive MS is associated with a higher risk for ...
- Targeting Abnormally Active B Cell Metabolism Reduces Multiple Sclerosis Symptoms
Abnormally active metabolism in B cells drives pro-inflammatory responses that lead to myelin being attacked by T cells. By targeting B cell metabolism, multiple sclerosis flare-ups are reduced.
- The Long and Evolving Relationship Between Viruses and Multiple Sclerosis
Multiple sclerosis (MS) is a demyelinating disorder of unknown etiology, possibly caused by a virus or is virus-triggered. Several viruses, including herpesviruses, were suggested as etiologic ...
Go deeper with Google Headlines on:
Multiple sclerosis
[google_news title=”” keyword=”multiple sclerosis” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]